KPLH1130 T11765
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
KPLH1130 improves glucose tolerance in HFD-fed mice.�KPLH1130 is a specific pyruvate dehydrogenase kinase (PDK) inhibitor, blocks macrophage polarization and attenuates proinflammatory responses.
CAS nr:
906669-07-6
Purity:
98%
Molecular Weight:
283,28
SMILES:
O=C1NN=C(C2=CC=C(O)C=C2O)N1C3=CC=C(C)C=C3
Formula:
C15H13N3O3
Pathway:
Metabolism,PI3K/Akt/mTOR signaling
Target:
Dehydrogenase,PDK
